A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

ClinicalTrials.gov ID: NCT06933472

Public ClinicalTrials.gov record NCT06933472. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 11:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multi-Regional, Phase 3 Study to Evaluate the Efficacy and Safety of AP301 on Serum Phosphorus Control in Chronic Kidney Disease Patients Receiving Maintenance Dialysis With Hyperphosphatemia

Study identification

NCT ID: NCT06933472
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Alebund Pharmaceuticals; Industry
Enrollment: 264 participants

Conditions and interventions

Conditions

Interventions

AP301 Drug
AP301 Low Dose Drug

Drug

Eligibility (public fields only)

Age range: 12 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 12, 2025
Primary completion: Jun 19, 2026
Completion: Jan 9, 2027
Last update posted: Jan 28, 2026

2025 – 2027

United States locations

U.S. sites: 18
U.S. states: 11
U.S. cities: 17

Facility	City	State	ZIP	Site status
Renal Consultants Medical Group	Granada Hills	California	91344	Recruiting
North America Research Institute - San Dimas	San Dimas	California	91773	Recruiting
Rocky Mountain Kidney Care - Lone Tree	Lone Tree	Colorado	80124	Recruiting
PACT Kidney Care - Orange	Orange	Connecticut	06477	Recruiting
US Renal Care - Fort Myers South	Fort Myers	Florida	33912	Recruiting
Nephrology & Hypertension Specialists	Dalton	Georgia	30720	Recruiting
Renal Associates Of Baton Rouge, LLC	Baton Rouge	Louisiana	70808	Recruiting
Nephrology Associates, P.C. - Columbus	Columbus	Mississippi	38801	Recruiting
Nephrology & Hypertension Associates Ltd - Tupelo	Tupelo	Mississippi	38801	Recruiting
High Desert Nephrology Association - US Renal Care	Gallup	New Mexico	87301	Recruiting
US Renal Care - West Cheektowaga	Cheektowaga	New York	14215	Recruiting
NY Kidney & Hypertension Medicine	Ridgewood	New York	11385	Recruiting
US Renal Care - Alexis	Toledo	Ohio	43613	Recruiting
Dallas Renal Group - Dallas	Dallas	Texas	75237	Recruiting
US Renal Care - Bluebonnet	Fort Worth	Texas	76110	Recruiting
Gamma Medical Research	McAllen	Texas	78503	Recruiting
US Renal Care - South San Antonio	San Antonio	Texas	78211	Recruiting
US Renal Care - Hill Country	San Antonio	Texas	78251	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06933472, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 28, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06933472 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →